Talis Biomedical Corp
Change company Symbol lookup
Select an option...
TLIS Talis Biomedical Corp
DVN Devon Energy Corp
BCX BlackRock Resources & Commodities Strategy Trust
BRKS Brooks Automation Inc
OPEN Opendoor Technologies Inc
ADI Analog Devices Inc
HD Home Depot Inc
SIEN Sientra Inc
APPF Appfolio Inc
TGI Triumph Group Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.

Price
Delayed
$10.41
Day's Change
-0.07 (-0.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.09
Day's Low
10.05
Volume
(Below Average)

Today's volume of 46,360 shares is on pace to be lower than TLIS's 10-day average volume of 74,683 shares.

46,360

Baxter to Host First-Quarter 2021 Financial Results Conference Call for Investors

4:15 pm ET March 24, 2021 (BusinessWire) Print

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2021 financial results on Thursday, April 29, 2021 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/1693119 to pre-register for the call and receive the call information.

This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.

About Baxter

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005920/en/

SOURCE: Baxter International Inc.

Media Contact 
Steve Brett, (224) 948-5353
media@baxter.com

Investor Contact 
Clare Trachtman, (224) 948-3020
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.